Indian Journal of Cancer
Home  ICS  Feedback Subscribe Top cited articles Login
Users Online :163
Small font sizeDefault font sizeIncrease font size
Navigate Here
  »   My Preferences 
  »   Manuscript submission

 


Ahead of Print policy

Articles published online under the Ahead of Print model are considered published and can be cited and quoted using the DOI as the reference source. Wolters Kluwer Medknow has a policy that changes will not be made after publication of an article without following accepted procedures for making corrections to the scientific record.



 Coming soon

GUEST EDITORIAL
1.  Is hysterectomy needed in ovarian cancer?
ORIGINAL ARTICLE
1.  Gemcitabine and Docetaxel combination in treatment of anthracyclin-pretreated advanced soft tissue sarcoma
2.  Chemosuppressive Effect of Plumbagin on Human Non-Small Lung Cancer Cell Xenotransplanted Zebrafish
3.  Demographic, Clinical, Biochemical, Radiological and Etiological Characteristics of Malignant Pleural Effusions from Eastern India
4.  Risk factors for hematological toxicity of chemotherapy for bone and soft tissue sarcoma
5.  Chronic Myeloid Leukemia in Children and Adolescents: A single centre experience from India
6.  Percutaneous vertebroplasty and interventional tumor removal for spinal metastatic tumor without compression
7.  Role of Chemotherapy In the Management of Gestational Trophoblastic Disease : A Prospective Audit.
8.  Mutational Study of Kras in Bladder Cancer in Kashmiri population
9.  Relationship of clinicopathologic characteristic and treatment methods with prognosis of triple-negative breast cancer
10.  Inhibition of Lung Adenocarcinoma Cancer Cells by IGF-IR and KRAS Mutations: A Mutation Analysis With Antisense Oligodeoxynucleotide
11.  Palliative thoracic radiotherapy in advanced lung cancer: A Single institution experience
12.  Mutational Analysis of Erythropoietin Gene and its Enhancer in Anemic Cancer Patients
13.  Effects of Hippo pathway in colorectal cancer
14.  Outcomes in lung cancer: an experience from routine tertiary care setting
15.  Solitary pulmonary nodule evaluation in regions endemic for infectious diseases : Do regional variations impact the effectiveness of FDG PET/CT.
16.  METASTATIC NON-SMALL LUNG CANCER IN SOUTH INDIA: A REGIONAL DEMOGRAPHIC STUDY
17.  Role Of Pneumonectomy For Lung Cancer In Current Scenario: An Indian Perspective
18.  A PROSPECTIVE STUDY OF TELEPHONIC CONTACT AND SUBSEQUENT PHYSICAL FOLLOW UP OF RADICALLY TREATED LUNG CANCER PATIENTS
19.  Comparison studty of Quality of life in advanced lung cancer patients on Tyrosine kinase inhibitor and platinum doublet chemotherapy
20.  Metastasectomy for recurrent or metastatic biliary tract cancers: a single center experience.
21.  EGFR positive lung cancer : The non trial scenario
22.  A meta-analysis:evaluate The safety and efficacy of epidermal growth factor receptor-tyrosine kinase inhibitor monotherapy versus platinum-based doublets chemotherapy in East Asia
23.  Retrospectively Analysis of Icotinib Neoadjuvant Therapy for 63 Cases of Lung Cancer Patients
24.  Epidemiology of gynaecological cancers in Kamrup Urban District Cancer Registry
25.  Clinical profile of non small cell lung carcinoma patients treated in a single unit at a tertiary cancer care centre
26.  ROLE OF CRIZOTINIB IN C-MET POSITIVE NON-SMALL CELL LUNG CANCER PATIENTS – A CASE SERIES
27.  First line therapy outcomes in patients with advanced stage NSCLC treated at Non Government Tertiary care centre in India – experience from a real world practice
28.  Clinical profile and outcomes of patients with stage IV adenocarcinoma of lung – A tertiary cancer centre experience
29.  Evolving epidemiology of lung cancer in a tertiary care center in North India: reducing NSCLC-NOS and quantifying tobacco smoke exposure is the key
30.  Anaplastic lymphoma kinase (ALK) immunohistochemistry in lung adenocarcinomas: evaluation of performance of standard manual method using D5F3 antibody
31.  ALK status in lung cancers –an IHC and FISH study from a tertiary cancer centre in India
32.  DUAL MUTATIONS AND COMPLEX MUTATIONS IN METASTATIC NON SMALL CELL LUNG CANCER: A SINGLE INSTITUTION EXPERIENCE FROM SOUTH INDIA.
33.  Gemcitabine and carboplatin in metastatic nonsmall cell lung cancer: Experience from a tertiary cancer centre in South India
34.  The increasing challenge of never smokers with adenocarcinoma lung, need to look beyond tobacco exposure
35.  Study of Gefitinib maintenance in unselected patients with metastatic primary lung adenocarcinoma- Descriptive study.
36.  Lung Cancer -Presentation and Pattern of Care in a Cancer Centre in South India
37.  ACTUAL GAINS IN DOSIMETRY AND TREATMENT DELIVERY EFFICIENCY FROM VOLUMETRIC MODULATED ARC RADIOTHERAPY (VMAT) FOR INOPERABLE, LOCALLY-ADVANCED LUNG CANCER OVER FIVE FIELD FORWARD PLANNED INTENSITY MODULATED RADIOTHERAPY (5-F FORWARD IMRT)
38.  NEWER INSIGHTS INTO ALK POSITIVE NSCLC
39.  The efficacy and safety of preoperative chemotherapy for patients with non-small cell lung cancer: a meta-analysis
40.  Robotic resections in Hepatobiliary oncology – Initial Experience with Xi da Vinci system in India
41.  Induction chemotherapy in locally advanced T4b oral cavity squamous cell cancers: A regional cancer centre experience
42.  Tumor characteristics and metabolic quantification in Carcinoma Breast – An institutional experience
43.  HISTOPATHOLOGICAL ANALYSIS OF MENINGIOMA AND ITS VARIANTS – A STUDY OF 50 CASES.
44.  ORAL HEALTH RELATED QUALITY OF LIFE (OHRQoL) IN PATIENTS TREATED FOR ORAL MALIGNANCY AT KANCHIPURAM DISTRICT; INDIA: A CROSS SECTIONAL STUDY
45.  AN AUDIT AND ANALYSIS OF DIFFERENT CAUSES OF DEFAULTS IN PATIENTS RECEIVING RADIATION FOR HEAD AND NECK CANCERS - A TERTIARY REGIONAL CANCER CENTER EXPERIENCE.
46.  Testicular Seminoma: Are clinical features and Treatment outcomes any different in India?
47.  Composite lymphomas: Experience from a tertiary cancer centre in Kerala, South India
48.  MULTIPLE MYELOMA: EXPERIENCE OF AN INSTITUTE IN LIMITED RESOURCE SETTING
49.  Evaluation of Dose Conformity and Coverage of Target Volume for Intensity Modulated Radiotherapy of Pelvic Cancer Treatment.
50.  Indian consensus statement for treatment of advanced Non-Small Cell Lung Cancer: First line, maintenance and second line
51.  Retrospective analysis of palliative metronomic chemotherapy in head and neck cancer
52.  Comparison of paclitaxel -cetuximab chemotherapy versus metronomic chemotherapy consisting of methotrexate and celecoxib as palliative chemotherapy in head and neck cancers.
53.  CONTINUOUS HYPERFRACTIONATED ACCELERATED RADIOTHERAPY (CHART) USING MODERN RADIOTHERAPY TECHNIQUES FOR NON-SMALL CELL LUNG CANCER (NSCLC) PATIENTS UNSUITABLE FOR CHEMO-RADIATION
54.  Survival and prognostic factors for Glioblastoma multiformie- Retrospective single institutional study
55.  Stereotactic Body Radiation Therapy for hepatocellular carcinoma, experience from a tertiary cancer care center in India
56.  Retrospective study of efficacy and safety of neoadjuvant Docetaxel, Carboplatin and Trastuzumab (TCH) in HER2 positive locally advanced and oligometastatic breast cancer – An Indian experience
57.  “Comparision of Conventional fractionation (5 Fractions/week) and Altered fractionation (6 Fractions/week) in Stage I and II Squamous cell carcinoma of Oropharynx- An Institutional Study”
58.  Development and validation of a predictive score, for identifying poor ECOG PS (PS 3-4) advanced NSCLC patients who are likely to benefit from tyrosine kinase inhibitors
59.  Rechallenge temozolomide in Glioma : A case series from India
60.  Predicting locoregional recurrence risk in T1, T2 breast cancer with 1-3 positive axillary nodes post mastectomy: Development of a predictive nomogram
61.  Pattern of distant metastasis in molecular subtypes of Carcinoma Breast – An institutional study
62.  A PROSPECTIVE RANDOMIZED TRIAL COMPARING CAPECITABINE BASED CHEMORADIOTHERAPY WITH 5-FU BASED CHEMORADIOTHERAPY IN NEOADJUVANT SETTING IN LOCALLY ADVANCED CARCINOMA RECTUM
63.  Prognostic factors and treatment of patients with advanced Synovial Sarcoma, single center experience
64.  Efficacy and safety of first-line systemic chemotherapy with ECF and DCF regimens in locally advanced inoperable or metastatic gastric or gastro-esophageal junction (GEJ) adenocarcinoma - a prospective phase II study from south India
65.  Impect Of Induction Chemotherapy To Concurrent Chemoirradiation Over Radiotherapy Alone In Advanced Oral Cavity
66.  The comparision of thoracoscopic-laparoscopic esophagectomy and open esophagectomy: a meta-analysis
67.  Effect of tyrosine kinase inhibitors on the glucose levels in diabetic and nondiabetic patients
68.  CERITINIB IN ALK POSITIVE NSCLC AMONG PATIENTS WHO WERE PREVIOUSLY EXPOSED TO CRIZOTINIB: EXPERIENCE FROM THE INDIAN SUBCONTINENT
69.  Role and relevance of BRAF mutations in risk stratifying patients of papillary thyroid cancers along with a review of literature
70.  : ‘ A Comparative Analysis of Immunohistochemistry (IHC) & Fluorescent in situ Hybridization (FISH) assay to detect ALK status in lung adenocarcinoma cases ; a search for a testing algorithm’
71.  Repeat biopsy in EGFR mutation positive non-small cell lung cancer - Feasibility, limitations and clinical utility in Indian patients
72.  Incidence and characteristics of EGFR mutation in non-small-cell lung cancer (Adenocarcinoma histology): A report of 106 patients from Kolkata
73.  Long term outcome of Diffuse Large B cell lymphoma: Impact of biosimilar rituximab and radiation
74.  Molecular subtypes as a Predictor of Response to Neoadjuvant Chemotherapy in Breast Cancer Patients
75.  Quality of life outcome measures using University of Washington [UW-QOL]questionnaire version 4 inearly T1/T2 anterior tongue cancers with and without radiotherapy– a cross sectional study
76.  Stereotactic Body radiation therapy for early stage primary lung cancer, is an Active breath coordinator necessary? An audit from a tertiary cancer care Center
77.  The single-incision versus multiple-incision video-assisted thoracoscopic surgery in the treatment of lung cancer: a systematic review and meta-analysis
78.  Perioperative Complications Of Esophagectomy – Post Neo Adjuvant Treatment Versus Primary Surgery: Our Experience And Review Of Literature.
79.  Utilization of pelvic lymph node dissection in patients undergoing robot-assisted radical prostatectomy in India vs. the United States – A Vattikuti Collective Quality Initiative database analysis
80.  Clinico-Pathological Profile Of Colorectal Cancer In First Two Decade Of Life
81.  Reirradiation for recurrent primary central nervous system tumours: Eight year audit from a tertiary cancer care centre in south India
82.  Statins and Risk of Cancer: A Meta-analysis of Randomized, Double-blind, Placebo-controlled Trials
83.  ROLE CHANGE AS BREADWINNER IN CANCER CAREGIVING
84.  IMPACT OF PICTORIAL WARNING LABELS ON TOBACCO PRODUCTS AMONG PATIENTS ATTENDING OPD OF A DENTAL COLLEGE IN BANGALORE CITY: A CROSS- SECTIONAL STUDY
85.  Knowledge, Attitude and Practice towards Cervical Cancer among Women attending Obstetrics and Gynecology Department: A cross-sectional Hospital based survey in South India
86.  Critical histopathologic evaluation of 400 biopsies and resection specimens of trunk and extremity-based soft tissue tumors.
87.  Carboplatin based chemoradiation therapy in locally advanced head and neck cancer patients who are unfit for cisplatin therapy
88.  MR Imaging - A predictor of pathological tumour dimensions in carcinoma of anterior two thirds of tongue. A prospective evaluation Type Original Article
89.  Paralingual and sublingual space invasion in MR imaging of squamous cell carcinoma of anterior two thirds of tongue: Is there a prognostic significance? A prospective evaluation
90.  Role of laparoscopy in predicting surgical outcomes in patients undergoing interval cytoreduction surgery for advanced epithelial ovarian carcinoma: a prospective validation study
91.  Prognostic significance of p16INK4a ateration in soft tissue sarcomas:a meta-analysis
92.  Primary Neuroendocrine Carcinoma of the thymus: Retrospective Analysis from a Regional Cancer Center in Western India.
93.  Clinicopathological spectrum of teratomas: An eight year retrospective study from tertiary care institute”
94.  Prevalence of cytogenetic abnormalities in chronic lymphocytic leukemia in the southern part of Turkey
95.  Axillary dissection for breast cancer using Electrocautery versus Ultrasonic dissectors : A prospective randomised study
96.  Nasopharyngeal carcinoma : Experience and treatment outcome with radical conformal radiotherapy from a tertiary care center in India.
97.  Retrospective analysis of patients with relapsed or refractory testicular non- seminomatous germ cell tumors treated with autologous stem cell transplantation
98.  Prospective Analysis of Patients with Metastatic Breast Cancer receiving Eribulin Mesylate as second or more lines of Chemotherapy: An Indian Experience
99.  Microsatellite Instability in Chronic Myeloid Leukemia using D17S261 and D3S643 Markers- A Pilot Study in Western India
100.  Prevalence of Human Papilloma Virus in Oral Squamous Cell carcinoma: A rural teaching hospital based cross-sectional study
101.  ROS-1 Rearranged Non Small Cell Lung Cancer and Crizotinib: An Indian Experience
102.  Barriers affecting adherence to radiation treatment and strategies to overcome those barriers
103.  Radical radiotherapy for carcinoma larynx in the elderly: functional and oncological outcomes from an Indian tertiary care centre
104.  Metronomic Therapy in Metastatic Castrate Resistant Prostate Cancer: Experience from a Tertiary Cancer Care Center
105.  TEX triplet followed by continuation mono therapy in advanced gastric cancer.
106.  Compliance and outcomes of concurrent Chemo-radiation in patients with peri-ampullary tumors undergoing curative resections
107.  Comparison of Conventional Pap smear and Liquid Based Cytology: A Study of Cervical Cancer Screening at a Tertiary Care Centre in Bihar.
108.  Effect of Levamisole on expression of CD138 and Interleukin 6 in human multiple myeloma cell lines
109.  TRIPLE NEGATIVE BREAST CANCERS (TNBC): ARE THEY ALWAYS DIFFERENT FROM NON TNBC? AN EXPERIENCE FROM TERTIARY CENTRE IN INDIA
110.  Education differential in relation to tobacco use and its predictors across different regions of India
111.  Histopathological study of thirty nephrectomy specimens in a tertiary care hospital in North Telangana
112.  Clinico pathological profile of papillary carcinoma of thyroid–A ten year experience in a tertiary care institute in North Karnataka, India
113.  First-line tyrosine kinase inhibitors in metastatic renal cell carcinoma (mRCC): A regional cancer centre experience
114.  Short - term efficacy and safety of apatinib in advanced squamous cell lung cancer
115.  Non-trial, real world outcomes in ‘truly’ unresectable locally advanced pancreatic cancer- chemotherapy and chemoradiation is the norm while surgery is ‘truly’ uncommon
116.  Safety and antitumor activity of arsenic trioxide (ATO) plus infusional 5-FU, leucovorin and irinotecan (FOLFIRI) as second-line chemotherapy for refractory metastatic colorectal cancer: A pilot study from south India
117.  Advanced hepatocellular carcinoma (HCC): A regional cancer centre experience of 48 cases
118.  Quality assessment and improvement of cancer registration system in Kamrup Urban District : a report
119.  Antibiotic/Adjuvant Combinations (Ceftriaxone+ Sulbactam+Adjuvant Disodium Edetate) as an alternative empiric therapy for the treatment of nosocomial infections. Results of a retrospective study.
120.  Time Domain HRV Based Computer Aided Prognosis of Lung Cancer
121.  Comparative pharmacokinetics, efficacy and safety of bevacizumab biosimilar to reference bevacizumab in patients with metastatic colorectal cancer
122.  Gallbladder cancer incidence in Delhi urban: A 25-year trends analysis
123.  Interneural tissue clearance in axillary dissection for breast cancer: what is the importance?
124.  Cervical esophago-gastric anastomosis after esophagectomy, using linear cutter stapler in esophageal cancer.
125.  Novel Use of Bioelectric Impedence Technique to Detect Alterations Body Composition in Advanced Small Cell Lung Cancer
126.  Title: Clinical audit to assess delays in chemotherapy administration at day care Oncology center at a tertiary care hospital in Karachi, Pakistan. Running Title: Audit to assess delays in chemotherapy
127.  Impact of combined JAK2V617F mutation and the inherited thrombophilic factors on thrombotic risk in CMPNs: A retrospective study from India
128.  Clinico-epidemiological Profiles, Clinical Practices, and the Impact of Holistic Care Interventions on Outcomes of Pediatric hemato-lymphoid (PHL) Malignancies- A 6-year Audit of the PHL-Disease Management Group (DMG) at Tata Memorial Hospital
129.  Management outcomes of pediatric and adolescent papillary thyroid cancers with a brief review of literature
130.  Breast Cancer in India – An audit from a tertiary cancer centre with outcome analysis
131.  Retrospective analysis of patients of cervical cancer at tertiary center of Bihar
132.  Analysis of Bone and Soft Tissue Sarcomas Registered during the year 2012 at Tata Memorial Centre, including Clinical Outcomes.
133.  RADICAL RADIOTHERAPY OR CHEMORADIOTHERAPY FOR INOPERABLE, LOCALLY-ADVANCED, NON-SMALL CELL LUNG CANCER (NSCLC) - ANALYSIS OF PATIENT PROFILE, TREATMENT APPROACHES AND OUTCOMES FOR 213 PATIENTS AT A TERTIARY CANCER CENTRE
134.  Outcomes of Advanced Epithelial Ovarian Cancer Treated with Neoadjuvant Chemotherapy
135.  Surgical morbidities and outcomes of major salivary gland neoplasm treated at a tertiary cancer center.
136.  Total laryngectomy: surgical morbidity and outcomes- a case series
137.  A clinicopathological and immunohistochemical perspective of non-urothelial bladder tumours – A single centre study.
138.  Clinicopathological profile of lung cancer at a tertiary care centre
139.  A comparative analysis of Quality of life after postoperative IMRT or 3DCRT for cervical cancer
140.  Neoadjuvant chemo-radiation for locally advanced resectable carcinoma esophagus: a single-centre experience from India with a brief review of the literature
141.  A comparative phase III clinical study to evaluate TrastuRelTM (biosimilar trastuzumab) and innovator trastuzumab in patients with metastatic HER2-overexpressing breast cancer.
142.  Cetuximab in combination with chemoradiotherapy for nasopharyngeal carcinoma: a meta-analysis
143.  Outcomes of surgically treated oral cancer patients at a tertiary cancer centre in India.
144.  Locally Advanced Cervical Cancer: An audit of 5-year outcomes
145.  Primary cutaneous B-cell lymphoma: A single center 5-year experience
146.  TO EVALUATE THE INCIDENCE OF OESTROGEN RECEPTOR (ER), PROGESTERONE RECEPTOR (PR) AND HUMAN EPIDERMAL GROWTH FACTOR RECEPTOR 2 (HER2/NEU STATUS IN NEWLY DIAGNOSED BREAST CARCINOMA PATIENTS AT IGIMS PATNA
147.  Prognostic factors in parotid cancers: clinicopathological and treatment factors influencing outcomes
148.  Chylothorax in children with cancer: a milky predicament
149.  Outcomes with second line chemotherapy in advanced pancreatic cancers – a retrospective study from a tertiary cancer centre in India
150.  Treatment practices for metastatic pancreatic cancer – can we deliver an appropriately efficacious and safe regimen in Indian patients?
151.  Cell-free circulating tumor DNA in patients with high grade glioma as diagnostic biomarker-A guide to future directive
152.  Demographic profile, clinico-pathological spectrum, and treatment outcomes of primary central nervous system tumors: retrospective audit from an academic neuro-oncology unit
153.  Superficial Incisional Surgical Site Infections in emergency surgery in cancer patients: A tertiary cancer care centre experience.
154.  A comparative study of the effects of medical versus surgical androgen deprivation therapy on health related quality of life in patients with metastatic carcinoma prostate
155.  Surgical Outcomes of Thyroid Cancer Patients in a Tertiary Cancer Centre in India
156.  Metastatic thymic epithelial tumors (TET): A regional cancer centre experience
157.  Compliance to radiotherapy: A tertiary care center experience
158.  Radiological diagnosis alone risks over-treatment of benign disease in gall bladder cancer: A word of caution in an era of radical surgery
159.  Prostate cancer demographics and outcome data from 2013 at a tertiary cancer hospital in India.
ORIGINAL ARTICLE - ANTI TOBACCO ISSUE
1.  A study of changes in the oral fungal flora of patients on radiotherapy for head and neck malignancies and their correlation with funguria and fungemia
2.  Prevalence of Oro-mucosal Lesions in relation to Tobacco Habit among Western Maharashtra Population
3.  Multiple logistic regression analysis predicts cancer risk among tobacco usage with glutathione S-transferase p1 genotyping in head and neck cancer patients
4.  A Retrospective study on Lung Cancer in a regional cancer centre : New challenges for North- West India
REVIEW ARTICLE
1.  Mediastinal staging for non-small cell lung cancer revisited. It is being done under aegis of ICON and Lung cancer consortium asia.
2.  Pomalidomide in Multiple Myeloma
3.  Metformin use and survival of lung cancer patients: Meta-analysis Findings
4.  Venous Thromboembolism In Cancer Patients Magnitude Of Problem, Approach And Management A Review Article
5.  Related factors of postoperative gallstone formation after distal gastrectomy: A meta-analysis
6.  Is pulmonary metastatectomy beneficial in head and neck squamous cell carcinoma? A review of literature
7.  Is Pneumonectomy a Justified Procedure in Patients with Persistent N2 Non Small Cell Lung Cancer Disease Following Induction Therapy
8.  Targeted Therapy in Non-Small-Cell Lung Cancer
9.  Implementing American Joint Committee on Cancer 8th Edition for Head and Neck Cancer in India: Context, Feasibility and Practicality
LETTER
1.  “Uncommon central nervous system metastasis from primary epithelial ovarian carcinoma”.
2.  Hepatoid adenocarcinoma of the stomach – a rare histology of gastric adenocarcinoma in an adolescent: a case report.
3.  Cysticercosis masquerading as scar site recurrence in a post mastectomy Breast cancer patient
4.  Acute Promyelocytic Leukemia with PLZF-RAR positivity identified at molecular level – A case report
5.  Practical solutions to EGFR-TKI dose modifications in resource constrained settings: thinking outside the (packaging) box
6.  FDG avid Pulmonary mucinous adenocarcinoma presenting with non FDG avid cystic brain lesions of Unknown etiopathology: Brain MRI and FDG PET-CT imaging features and additional value of whole body PET acquisition
7.  Expanded panel test detecting mesenchymal‑epithelial transition amplification leading to effective treatment in adenocarcinoma lung
8.  Nivolumab instills hope in a hopeless situation in advanced NSCLC with poor performance status
9.  Sister Mary Josephæs nodule: Two rare cases of inoperable gallbladder cancer
10.  Atypical lung carcinoid -An Unusual Presentation
11.  Chemo port Insertion via Femoral Vein Approach – Rare Indication and Rare Complication
12.  Pediatric Chronic Myeloid Leukemia with myeloid blast crisis at presentation along with complex karyotype: a rare case report
13.  Medial planter artery perforator flap for reconstruction of the soft tissue defect of heel melanoma.
14.  Summer school in oncology – setting a benchmark in inspiring the future oncologists - a surgical post graduate’s perspective
15.  Case of eccrine spiradenoma from India- A rare adnexal tumor
16.  Locally aggressive recurrent Inflammatory myofibroblastic tumor in a rare extrapulmonary location.
EDITORIAL
1.  Tuberculosis in EGFR mutation Adenocarcinoma lung on Treatment with Gefitinib/ Erlotinib
2.  Neoadjuvant Chemotherapy for Unresectable Oral Cancers: Optimizing Outcomes?


  Site Map | What's new | Copyright and Disclaimer
  Online since 1st April '07
  © 2007 - Indian Journal of Cancer | Published by Wolters Kluwer - Medknow